StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Durect Corporation

Enter Symbol or Keywords

Durect's Cash Flow from Operations Hits Nine Year High

Stock Quote: (NGM:DRRX)

11/11/2009

2.01

+0.06

+3.08%

132,377

Durect's Cash Flow from Operations Hits Nine Year High

Last

Price Change

% Chg

Volume

New York, NY, November 11, 2009-CFFO-NEWS reports that negative Cash Flow from Operations (CFFO) for Durect Corporation (NASDAQ:DRRX) for its twelve months ended September 30, 2009 was $(2,088,000), a ... read full story

Website Address:	www.durect.com
Industry:	Drug Delivery Systems

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: DRRX

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: DRRX

11/13/2009

Three Year High in EBITDA for Durect

11/11/2009

Durect bucks its Industry’s Revenue Decline of -7.1% with an Increase of 0.14%

11/11/2009

OPS Ranking of "7" for Durect Reiterated by StockDiagnostics.com

... more DRRX exclusives

Other News Sources: DRRX

01/19/2010

DRRX: Begins Dosing in Phase III Trial of POSIDUR(TM) for Post-Surgical Pain

01/19/2010

DRRX: Conference call regarding DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial @ 11:00 ET Today

01/19/2010

DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial

... more DRRX news from other sources

Daily Market Updates

02/09/2010

Markets Close Day After Strong Rally as Concerns Ease re Greece

Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story